Sponsor:
Immunis.AI
Code:
NCT04052048
Conditions
Prostate Cancer Aggressiveness
Eligibility Criteria
Sex: Male
Age: 40 - 70+
Healthy Volunteers: Not accepted
Interventions
Subtraction Normalized Expression of Phagocytes Blood Test
Brief summary:
Conditions
Prostate Cancer Aggressiveness
Study ID
NCT04052048
Start date
Sep 9, 2019
Status verified date
Mar, 2026
Completion date
Sep 30, 2029
Anticipated
Primary completion date
Nov 15, 2026
Anticipated
Eligibility Criteria
Sex: Male
Age: 40 - 70+
Healthy Volunteers: Not accepted
Enrollment
2000 participants
Anticipated
Interventions
Subtraction Normalized Expression of Phagocytes Blood Test
Primary outcome measure
Central contacts
Locations
Comprehensive Urology
Recruiting
Royal Oak, Michigan, United States, 48197
Contacts
Principal Investigator:
Howard Korman, MD
Sponsor
Immunis.AI
Last update posted
Apr 2, 2026
Last verified
Mar, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Immunis.AI on 2026-04-02.